chitosan has been researched along with Liver Failure, Acute in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, D; Ren, H; Shang, L; Wang, J; Yu, H | 1 |
| Ding, YT; Ma, HC; Shi, XL; Tan, JJ; Xiao, JQ; Xu, Q | 1 |
| Ding, YT; Shi, XL; Tan, JJ; Xiao, JQ; Xu, Q; Zhang, L | 1 |
| Chang, RA; Chen, Z; Li, ZF | 1 |
| Chang, YL; Chiang, CH; Chien, CS; Chien, Y; Chiou, SH; Huang, CS; Hung, SI; Huo, TI; Lai, YH; Lan, YT; Lee, SD; Li, HY; Lin, AT; Liu, DM; Peng, CH; Sun, CC; Wang, CY; Wu, WW | 1 |
| Chen, J; Dong, L; Gao, S; Xia, S; Zhang, C; Zhang, J; Zuo, L | 1 |
| Kim, SK; Kwon, CH; Lee, DH; Lee, JH; Lee, SK; Park, JK | 1 |
| Basu, S; Klein, MD; Matthew, HW; Peterson, WD; Salley, SO | 1 |
8 other study(ies) available for chitosan and Liver Failure, Acute
| Article | Year |
|---|---|
Biohybrid Response Microparticles Decorated with Trained-MSCs for Acute Liver Failure Recovery.
Topics: Animals; Anti-Inflammatory Agents; Chitosan; Lipopolysaccharides; Liver Failure, Acute; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Rats | 2022 |
Administration of IL-1Ra chitosan nanoparticles enhances the therapeutic efficacy of mesenchymal stem cell transplantation in acute liver failure.
Topics: Animals; Cell Proliferation; Cells, Cultured; Chitosan; Cytokines; Delayed-Action Preparations; Drug Carriers; Drug Synergism; Hepatocytes; Interleukin 1 Receptor Antagonist Protein; Liver Failure, Acute; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nanoparticles; Random Allocation; Swine | 2013 |
[A novel treatment regimen for acute liver failure based on a combination of mesenchymal stem cells transplantation and IL-lRa-loaded chitosan nanoparticles].
Topics: Chitosan; Liver Failure, Acute; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Nanoparticles | 2013 |
Role of HGF-loaded nanoparticles in treating rat acute hepatic failure.
Topics: Animals; Biomarkers; Cells, Cultured; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Disease Models, Animal; Drug Carriers; Female; Hepatocyte Growth Factor; Hepatocytes; Injections, Intraperitoneal; Injections, Intravenous; Ki-67 Antigen; Lactic Acid; Liver Failure, Acute; Liver Regeneration; Male; Mitotic Index; Nanoparticles; Polyesters; Polymers; Rats; Rats, Sprague-Dawley; Time Factors | 2013 |
Enhanced antioxidant capacity of dental pulp-derived iPSC-differentiated hepatocytes and liver regeneration by injectable HGF-releasing hydrogel in fulminant hepatic failure.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Bilirubin; Cell Differentiation; Cells, Cultured; Cellular Reprogramming; Chitosan; Dental Pulp; Female; Hepatocyte Growth Factor; Hepatocytes; Humans; Hydrogel, Polyethylene Glycol Dimethacrylate; Induced Pluripotent Stem Cells; Liver; Liver Failure, Acute; Liver Regeneration; Male; Malondialdehyde; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Mice, Nude; Reactive Oxygen Species; Thioacetamide | 2015 |
Reduction of liver tumor necrosis factor-alpha expression by targeting delivery of antisense oligonucleotides into Kupffer cells protects rats from fulminant hepatitis.
Topics: Animals; Chitosan; Drug Carriers; Female; Galactosamine; Gene Targeting; Gene Transfer Techniques; Humans; Kupffer Cells; Lipopolysaccharides; Liver; Liver Failure, Acute; Oligonucleotides, Antisense; Rats; Rats, Sprague-Dawley; Survival Rate; Tumor Necrosis Factor-alpha | 2009 |
Effect of fulminant hepatic failure porcine plasma supplemented with essential components on encapsulated rat hepatocyte spheroids.
Topics: Albumins; Alginates; Animals; Bioreactors; Cell Survival; Cells, Immobilized; Chitosan; Culture Media; Disease Models, Animal; Glucuronic Acid; Hepatocytes; Hexuronic Acids; Humans; Liver Failure, Acute; Liver, Artificial; Male; Plasma; Rats; Rats, Sprague-Dawley; Spheroids, Cellular; Swine; Time Factors; Urea | 2012 |
Performance of plasma-perfused, microencapsulated hepatocytes: prospects for extracorporeal liver support.
Topics: Albumins; Animals; Antipyrine; Carboxymethylcellulose Sodium; Cells, Cultured; Chitin; Chitosan; Chondroitin Sulfates; Culture Media; Drug Compounding; Extracorporeal Circulation; Feasibility Studies; Hemostatics; Heparin; Humans; Liver; Liver Failure, Acute; Male; Pectins; Plasma; Rabbits; Time Factors; Transferrin; Urea | 1993 |